Fundz

Fundz Deep Dive

Everything you need to win VIVIO — in one platform.

Who to reach, what to say, and why now on VIVIO — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on VIVIO — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

VIVIO Launches PrecisionCare One™ to Transform Specialty Drug Management in Healthcare

Nov 25, 2024•over 1 year ago
HaywardBiotechnologyHealth CareMedical

Product Description

During a landmark webinar, VIVIO announced PrecisionCare One™, expanding its open-market specialty drug management platform to include all drugs, addressing healthcare cost issues caused by Pharmacy Benefit Managers (PBMs). This new program aims to apply VIVIO's clinical-first approach to all medications, seeking to revolutionize healthcare purchasing and eliminate hidden fees and anti-competitive practices.

Company Information

Company

VIVIO

Location

Hayward, California, United States

About

VIVIO is a Public Benefit Corporation focused on innovative solutions in healthcare, specifically in managing specialty drugs. Their approach emphasizes clinical expertise combined with open market principles to deliver cost-effective outcomes in various therapeutic areas. VIVIO aims to redefine healthcare economics by eliminating traditional intermediaries and fostering transparency. Their latest initiative, PrecisionCare One™, expands their platform to include all drugs, addressing the complexities of medication management.

Predictive Intelligence
Strategic

ML-powered predictions for VIVIO's next move

Learn about Strategic plan

Product Launch Insights

Based on market data
Market expansion signals
New product launches often coincide with market expansion initiatives

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.